This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0.  For a full list of available versions, see the Directory of published versions 
| Orders and Observations Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner | 
This is the narrative for the resource. See also the XML, JSON or Turtle format.
              Gene                DNAVariation       Status        Interpretation
              BRCA1                                 Negative
              BRCA2                 185delAG        Positive         Pathogenic
          
						Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Issued: 2015-05-26T15:30:10+01:00
FamilyMemeberHistory: Mother
              Gene                 DNAVariation      Status
              BRCA2                 185delAG        Positive
          
						Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.